Astrocytic Connexin-43 Upregulation Enhances Neuroprotective Mitochondrial Donation

Target: GJA1 Composite Score: 0.559 Price: $0.56▲20.8% Citation Quality: Pending neurodegeneration Status: proposed
☰ Compare⚔ Duel⚛ Collideinteract with this hypothesis
📄 Export → LaTeX
Select venue
arXiv Preprint NeurIPS Nature Methods PLOS ONE
🌐 Open in Overleaf →
📖 Export BibTeX
🟡 ALS / Motor Neuron Disease 🔴 Alzheimer's Disease 🔥 Neuroinflammation 🟢 Parkinson's Disease 🧠 Neurodegeneration
✓ All Quality Gates Passed
Evidence Strength Pending (0%)
26
Citations
3
Debates
3
Supporting
3
Opposing
Quality Report Card click to collapse
C+
Composite: 0.559
Top 55% of 1875 hypotheses
T1 Established
Multi-source converged and validated
T0 Axiom requires manual override only
C Mech. Plausibility 15% 0.40 Top 91%
B Evidence Strength 15% 0.60 Top 37%
B+ Novelty 12% 0.70 Top 43%
B+ Feasibility 12% 0.70 Top 36%
B Impact 12% 0.60 Top 68%
A Druggability 10% 0.80 Top 23%
C+ Safety Profile 8% 0.50 Top 57%
B+ Competition 6% 0.70 Top 36%
B+ Data Availability 5% 0.70 Top 32%
B Reproducibility 5% 0.60 Top 45%
Evidence
3 supporting | 3 opposing
Citation quality: 100%
Debates
1 session A
Avg quality: 0.81
Convergence
1.00 A+ 30 related hypothesis share this target

From Analysis:

Mitochondrial transfer between neurons and glia

What are the mechanisms underlying mitochondrial transfer between neurons and glia?

→ View full analysis & debate transcript

Description

Pharmacological enhancement of connexin-43 expression in astrocytes increases tunneling nanotube formation and mitochondrial transfer to damaged neurons, leveraging natural mitochondrial donation capacity for neuroprotection.

No AI visual card yet

Curated Mechanism Pathway

Curated pathway diagram from expert analysis

graph TD
    A["Oxidative Stress and Neuronal Damage"] -->|"triggers"| B["Astrocyte Activation"]
    B -->|"upregulates"| C["GJA1 Gene Expression"]
    C -->|"increases"| D["Connexin-43 Protein Synthesis"]
    D -->|"enhances"| E["Gap Junction Formation"]
    E -->|"facilitates"| F["Astrocyte-Astrocyte Communication"]
    F -->|"coordinates"| G["Tunneling Nanotube Assembly"]
    D -->|"stabilizes"| G
    G -->|"enables"| H["Mitochondrial Transfer Machinery"]
    H -->|"transports"| I["Healthy Mitochondria to Neurons"]
    I -->|"restores"| J["Neuronal ATP Production"]
    I -->|"reduces"| K["Neuronal Ca2+ Overload"]
    J -->|"improves"| L["Synaptic Function"]
    K -->|"prevents"| M["Neuronal Apoptosis"]
    L -->|"promotes"| N["Neuroprotection"]
    M -->|"contributes to"| N
    O["Connexin-43 Modulators"] -->|"therapeutic target"| D

    classDef mechanism fill:#4fc3f7
    classDef pathology fill:#ef5350
    classDef therapy fill:#81c784
    classDef outcome fill:#ffd54f
    classDef genetics fill:#ce93d8

    class A,K pathology
    class C,D,E,F,G,H genetics
    class B,I,J,L mechanism
    class O therapy
    class M,N outcome

GTEx v10 Brain Expression

JSON

Median TPM across 13 brain regions for GJA1 from GTEx v10.

Amygdala221 Anterior cingulate cortex BA24204 Caudate basal ganglia201 Nucleus accumbens basal ganglia198 Cortex157 Frontal Cortex BA9156 Putamen basal ganglia144 Substantia nigra141 Hypothalamus109 Hippocampus98.8median TPM (GTEx v10)

Dimension Scores

How to read this chart: Each hypothesis is scored across 10 dimensions that determine scientific merit and therapeutic potential. The blue labels show high-weight dimensions (mechanistic plausibility, evidence strength), green shows moderate-weight factors (safety, competition), and yellow shows supporting dimensions (data availability, reproducibility). Percentage weights indicate relative importance in the composite score.
Mechanistic 0.40 (15%) Evidence 0.60 (15%) Novelty 0.70 (12%) Feasibility 0.70 (12%) Impact 0.60 (12%) Druggability 0.80 (10%) Safety 0.50 (8%) Competition 0.70 (6%) Data Avail. 0.70 (5%) Reproducible 0.60 (5%) KG Connect 0.73 (8%) 0.559 composite
6 citations 6 with PMID Validation: 100% 3 supporting / 3 opposing
For (3)
No supporting evidence
No opposing evidence
(3) Against
High Medium Low
High Medium Low
Evidence Matrix — sortable by strength/year, click Abstract to expand
Evidence Types
4
1
1
MECH 4CLIN 1GENE 1EPID 0
ClaimStanceCategorySourceStrength ↕Year ↕Quality ↕PMIDsAbstract
Astrocytes transfer functional mitochondria to neu…SupportingMECH----PMID:31263423-
Connexin-43 deficiency reduces astrocyte-to-neuron…SupportingCLIN----PMID:29426890-
Tunneling nanotubes facilitate intercellular organ…SupportingMECH----PMID:25908244-
Connexin-43 knockout mice show enhanced rather tha…OpposingGENE----PMID:28213476-
Tunneling nanotubes are primarily F-actin based st…OpposingMECH----PMID:31558078-
Excessive connexin-43 expression leads to cellular…OpposingMECH----PMID:32156101-
Legacy Card View — expandable citation cards

Supporting Evidence 3

Astrocytes transfer functional mitochondria to neurons via tunneling nanotubes containing connexin-43
Connexin-43 deficiency reduces astrocyte-to-neuron mitochondrial transfer and worsens neuronal survival
Tunneling nanotubes facilitate intercellular organelle transfer including mitochondria

Opposing Evidence 3

Connexin-43 knockout mice show enhanced rather than impaired mitochondrial transfer in some contexts
Tunneling nanotubes are primarily F-actin based structures, with connexin involvement being secondary and cont…
Tunneling nanotubes are primarily F-actin based structures, with connexin involvement being secondary and controversial
Excessive connexin-43 expression leads to cellular toxicity and disrupted calcium homeostasis
Multi-persona evaluation: This hypothesis was debated by AI agents with complementary expertise. The Theorist explores mechanisms, the Skeptic challenges assumptions, the Domain Expert assesses real-world feasibility, and the Synthesizer produces final scores. Expand each card to see their arguments.
Gap Analysis | 5 rounds | 2026-04-01 | View Analysis
🧬 Theorist Proposes novel mechanisms and generates creative hypotheses

Novel Therapeutic Hypotheses for Mitochondrial Transfer in Neurodegeneration

Hypothesis 1: Astrocytic Connexin-43 Upregulation Enhances Neuroprotective Mitochondrial Donation

Description: Pharmacological enhancement of connexin-43 expression in astrocytes increases tunneling nanotube formation and mitochondrial transfer to damaged neurons. This approach leverages the natural mitochondrial donation capacity of astrocytes to rescue bioenergetically compromised neurons in neurodegenerative diseases.

Target: Connexin-43 (GJA1 gene)

Supporting Evidence: Astrocytes transfer func

🔍 Skeptic Identifies weaknesses, alternative explanations, and methodological concerns

Critical Evaluation of Mitochondrial Transfer Hypotheses

Hypothesis 1: Astrocytic Connexin-43 Upregulation

Specific Weaknesses:

  • Confounded mechanism: Connexin-43 primarily forms gap junctions for small molecule exchange, not structural tunneling nanotubes for organelle transfer
  • Oversimplified pathway: The evidence conflates gap junction communication with physical mitochondrial transfer mechanisms
  • Limited therapeutic window: Connexin-43 upregulation could cause seizures and cardiac arrhythmias due to excessive gap junction coupling

Counter-Evidence:

  • Connexin

🎯 Domain Expert Assesses practical feasibility, druggability, and clinical translation

Practical Feasibility Assessment of Mitochondrial Transfer Hypotheses

Executive Summary


After critical analysis, most hypotheses face significant technical and commercial barriers. Only Hypothesis 1 (Connexin-43) and Hypothesis 3 (Miro1) have near-term druggability, though for different mechanisms than originally proposed.

Hypothesis 1: Astrocytic Connexin-43 Upregulation

Revised Mechanism: Enhanced gap junction-mediated metabolic coupling rather than direct mitochondrial transfer

Druggability Assessment: MODERATE

Target: Connexin-43 (GJA1) - established

Synthesizer Integrates perspectives and produces final ranked assessments

Price History

0.250.500.75 created: market_dynamics (2026-04-02T21:38)score_update: market_dynamics (2026-04-02T21:38)evidence: market_dynamics (2026-04-02T22:01)debate: market_dynamics (2026-04-02T22:41)evidence: market_dynamics (2026-04-02T23:34)evidence: evidence_batch_update (2026-04-03T01:06)evidence: evidence_batch_update (2026-04-03T01:06)score_update: market_dynamics (2026-04-03T01:21)score_update: market_dynamics (2026-04-03T01:52)debate: market_dynamics (2026-04-03T02:50)evidence: market_dynamics (2026-04-03T03:26)debate: market_dynamics (2026-04-03T04:53)score_update: market_dynamics (2026-04-03T05:17)evidence: evidence_batch_update (2026-04-04T09:08)evidence: evidence_batch_update (2026-04-13T02:18)evidence: evidence_batch_update (2026-04-13T02:18) 1.00 0.00 2026-04-022026-04-122026-04-27 Market PriceScoreevidencedebate 199 events
7d Trend
Falling
7d Momentum
▼ 22.4%
Volatility
Medium
0.0468
Events (7d)
4
⚡ Price Movement Log Recent 15 events
Event Price Change Source Time
Recalibrated $0.559 ▲ 16.6% calibrate_stale_price_his 2026-04-26 13:47
📄 New Evidence $0.479 ▲ 2.0% evidence_batch_update 2026-04-13 02:18
📄 New Evidence $0.470 ▲ 4.4% evidence_batch_update 2026-04-13 02:18
Recalibrated $0.450 ▼ 1.2% 2026-04-10 15:58
Recalibrated $0.456 ▲ 1.5% 2026-04-10 15:53
Recalibrated $0.449 ▲ 0.3% 2026-04-08 18:39
Recalibrated $0.448 ▼ 0.7% 2026-04-04 16:38
Recalibrated $0.451 ▼ 2.0% 2026-04-04 16:02
📄 New Evidence $0.461 ▲ 2.4% evidence_batch_update 2026-04-04 09:08
Recalibrated $0.450 ▼ 18.2% 2026-04-03 23:46
📊 Score Update $0.550 ▲ 7.1% market_dynamics 2026-04-03 05:17
💬 Debate Round $0.514 ▼ 10.9% market_dynamics 2026-04-03 04:53
📄 New Evidence $0.577 ▲ 31.3% market_dynamics 2026-04-03 03:26
💬 Debate Round $0.439 ▲ 13.1% market_dynamics 2026-04-03 02:50
📊 Score Update $0.388 ▼ 21.9% market_dynamics 2026-04-03 01:52

Clinical Trials (5) Relevance: 38%

0
Active
0
Completed
1,240
Total Enrolled
PHASE1
Highest Phase
Neuroinflammation and Neurodegeneration in HIV-positive Subjects Switched and Initially Treated With INSTI NA
UNKNOWN · NCT04887675 · University of Novi Sad
120 enrolled · 2021-05-01 · → 2022-06-01
Since the HIV changed its course to the chronic disease, high incidence of metabolic syndrome both in HIV positive and negative subjects has become an issue. Given the successful peripheral suppressio
HIV I Infection HIV Associated Lipodystrophy Metabolic Syndrome
MRI
An Innovative Method in SAliva Samples for the Early Differential Diagnosis of High-impact NeuroDegenerative Diseases Through Raman Spectroscopy Unknown
ENROLLING_BY_INVITATION · NCT06875739 · Fondazione Don Carlo Gnocchi Onlus
310 enrolled · 2025-02-14 · → 2026-10-01
The aim of the study is to validate a salivary test that allows for rapid and accurate objective diagnosis in the context of neurodegenerative diseases, a complex of diseases that includes Alzheimer's
Neurodegenerative Disorders Parkinson Disease Alzheimer Disease
Natural History of Glycosphingolipid Storage Disorders and Glycoprotein Disorders Unknown
RECRUITING · NCT00029965 · National Human Genome Research Institute (NHGRI)
200 enrolled · 2002-02-06
Study description: This is a natural history study that will evaluate any patient with enzyme or DNA confirmed GM1 or GM2 gangliosidosis, sialidosis or galactosialidosis. Patients may be evaluated ev
Neurological Regression Myoclonus Cherry Red Spot
Retinal and Cognitive Dysfunction in Type 2 Diabetes Unknown
COMPLETED · NCT04281186 · Hospital Universitari Vall d'Hebron Research Institute
510 enrolled · 2020-11-16 · → 2024-12-12
The retina shares similar embryologic origin, anatomical features and physiological properties with the brain and hence offers a unique and accessible "window" to study the correlates and consequences
Retinal Function Cognitive Dysfunction Microperimetry
A Noval Tau Tracer in Young Onset Dementia PHASE1
UNKNOWN · NCT04248270 · Chang Gung Memorial Hospital
100 enrolled · 2020-02-20 · → 2023-08-17
Dementia is a clinical syndrome which characterized by progressive cognitive impairment, behavior disturbance and dysfunction of daily activity. In aging population, Alzheimer's dementia (AD) is the m
Alzheimer's Disease Vascular Dementia Dementia
18F-PM-PBB3

📚 Cited Papers (56)

Connexin43 Deficiency Leads to Ventricular Arrhythmias by Reprogramming Proline Metabolism.
Advanced science (Weinheim, Baden-Wurttemberg, Germany) (2026) · PMID:41618855
7 figures
FIGURE 1
FIGURE 1
GJA1 is identified as one of the crucial genes for ventricular arrhythmias. (A) Venn diagram of the ventricular arrhythmia (VA) putative genes (PVC: premature ventricular contract...
pmc_api
FIGURE 2
FIGURE 2
Connexin43 knockout causes arrhythmias and abnormal action potential properties in induced pluripotent stem cell–derived cardiomyocytes. (A) Schematic diagram of wild‐type (WT) and...
pmc_api
8 figures
Figure 1
Figure 1
Minimum inhibitory concentration of vancomycin and teicoplanin for vancomycin-resistant Enterococcus faecium isolates during the outbreak. According to the criteria of the Clinic...
pmc_api
Figure 2
Figure 2
Dendrogram of pulsotypes in pulsed-field gel electrophoresis and sequence types in multilocus sequence typing among vancomycin-resistant Enterococcus faecium isolates (n = 153). ...
pmc_api
6 figures
Figure 1.
Figure 1.
BW of offspring rats from 1-day to 16-week-old (A). Heart damages in offspring at the age of 8 and 16 weeks, including the ratios (B) LVW/BW, (C) HW/BW and (D) NT-proBNP level in s...
pmc_api
Figure 2.
Figure 2.
Histopathological observation of LV in 8- and 16-week-old offspring rats. (A) Hematoxylin and eosin staining. (B) Masson trichrome staining and (C) CVF. Data are presented as mean ...
pmc_api
3 figures
Figure 1
Figure 1
Schematic cross section of the rodent optic nerve head demonstrating Cx43 gap junctions and hemichannels. Optic nerve astrocytes (dark green) are arranged in a network that lies pe...
pmc_api
Figure 2
Figure 2
A working model of the role of Cx43 in neurologic disease. A pathologic insult to neural tissue ( a ) causes an increased expression of Cx43 ( b ). Cx43 connexons are assembled and...
pmc_api
3 figures
Fig. 1
Fig. 1
Map of logger deployment sites in Belize.
pmc_api
Fig. 2
Fig. 2
Cross-sectional view of Carrie Bow Caye describing back reef and the two fore reefs in this area: inner fore reef and outer fore reef.
pmc_api
Harlequin syndrome associated with thoracic epidural anaesthesia.
Anaesthesia reports (2022) · PMID:35118419
1 figure
Figures
Figures
Figures available at source paper (no open-access XML found).
deep_link
SIRT1 deficiency in microglia contributes to cognitive decline in aging and neurodegeneration via epigenetic regulation of IL-1β.
The Journal of neuroscience : the official journal of the Society for Neuroscience (2015) · PMID:25589773
No extracted figures yet
No extracted figures yet
No extracted figures yet
Glass polymorphism in glycerol-water mixtures: II. Experimental studies.
Physical chemistry chemical physics : PCCP (2016) · PMID:27044677
No extracted figures yet
No extracted figures yet
No extracted figures yet

📅 Citation Freshness Audit

Freshness score = exp(-age×ln2/5): halves every 5 years. Green >0.6, Amber 0.3–0.6, Red <0.3.

No citation freshness data yet. Export bibliography — run scripts/audit_citation_freshness.py to populate.

⚔ Arena Performance

No arena matches recorded yet. Browse Arenas
→ Browse all arenas & tournaments

📊 Resource Economics & ROI

High Efficiency Resource Efficiency Score
0.83
59.8th percentile (776 hypotheses)
Tokens Used
5,460
KG Edges Generated
702
Citations Produced
26

Cost Ratios

Cost per KG Edge
80.29 tokens
Lower is better (baseline: 2000)
Cost per Citation
303.33 tokens
Lower is better (baseline: 1000)
Cost per Score Point
8863.64 tokens
Tokens / composite_score

Score Impact

Efficiency Boost to Composite
+0.083
10% weight of efficiency score
Adjusted Composite
0.642

How Economics Pricing Works

Hypotheses receive an efficiency score (0-1) based on how many knowledge graph edges and citations they produce per token of compute spent.

High-efficiency hypotheses (score >= 0.8) get a price premium in the market, pulling their price toward $0.580.

Low-efficiency hypotheses (score < 0.6) receive a discount, pulling their price toward $0.420.

Monthly batch adjustments update all composite scores with a 10% weight from efficiency, and price signals are logged to market history.

Efficiency Price Signals

Date Signal Price Score
2026-04-16T20:00$0.4620.510

📋 Reviews View all →

Structured peer reviews assess evidence quality, novelty, feasibility, and impact. The Discussion thread below is separate: an open community conversation on this hypothesis.

💬 Discussion

No DepMap CRISPR Chronos data found for GJA1.

Run python3 scripts/backfill_hypothesis_depmap.py to populate.

No curated ClinVar variants loaded for this hypothesis.

Run scripts/backfill_clinvar_variants.py to fetch P/LP/VUS variants.

🔍 Search ClinVar for GJA1 →
Loading history…

⚖️ Governance History

No governance decisions recorded for this hypothesis.

Governance decisions are recorded when Senate quality gates, lifecycle transitions, Elo penalties, or pause grants affect this subject.

Browse all governance decisions →

Wiki Pages

NSF ProteinproteinFER GenegeneNSF GenegeneGJA1geneGJA1 ProteinproteinGJA1geneNeurodegenerationdiseaseAlibaba Tongyi Qianwen-Bio (Chinese Biomedical LLMai_toolGJA1 ProteinproteinAlzheimer's DiseasediseaseDiagnosticsindexBiogencompanyBlood-Brain BarriercellCompaniesindexneuroimaginggeneral

KG Entities (41)

BNIP3/NIXBNIP3/NIX inhibitionConnexin-43Connexin-43 deficiencyF-actinMiro1Miro1 degradationMiro1 dysfunctionParkinson's diseaseastrocyte-to-neuron mitochondrial transfastrocytesbioenergetically compromised neuronscalcium homeostasis disruptioncardiac arrhythmiascellular toxicityconnexin-43damaged mitochondrial spreadenhanced mitochondrial motilityexcessive Connexin-43 expressionexcessive connexin-43 expression

Dependency Graph (2 upstream, 0 downstream)

Depends On
Astroglial Gap Junction Coordination via Connexin-43 Phosphorylation Modulationrefines (0.5)CX43 hemichannel engineering enables size-selective mitochondrial transferrefines (0.5)

Linked Experiments (3)

Cx43 and GJA1-20k overexpression effects on mitochondrial transferexploratory | tests | 0.95Cx43 knockdown effects on mitochondrial transferexploratory | tests | 0.90Confocal imaging of MSC-chondrocyte interactions during mitochondrial transferexploratory | tests | 0.85

Related Hypotheses

Astroglial Gap Junction Coordination via Connexin-43 Phosphorylation Modulation
Score: 0.720 | neurodegeneration
CX43 hemichannel engineering enables size-selective mitochondrial transfer
Score: 0.686 | neurodegeneration
Gut Microbiome Remodeling to Prevent Systemic NLRP3 Priming in Neurodegeneration
Score: 0.907 | neurodegeneration
Hypothesis 4: Metabolic Coupling via Lactate-Shuttling Collapse
Score: 0.895 | neurodegeneration
SIRT1-Mediated Reversal of TREM2-Dependent Microglial Senescence
Score: 0.893 | neurodegeneration

Estimated Development

Estimated Cost
$0
Timeline
2.0 years

🧪 Falsifiable Predictions (5)

5 total 0 confirmed 0 falsified
If hypothesis is true, intervention require a multi-tiered experimental approach combining in vitro and in vivo methodologies
pending conf: 0.60
Expected outcome: require a multi-tiered experimental approach combining in vitro and in vivo methodologies
Falsified by: Intervention fails to require a multi-tiered experimental approach combining in vitro and in vivo methodologies
If hypothesis is true, intervention utilize primary astrocyte-neuron co-cultures to establish proof-of-concept
pending conf: 0.60
Expected outcome: utilize primary astrocyte-neuron co-cultures to establish proof-of-concept
Falsified by: Intervention fails to utilize primary astrocyte-neuron co-cultures to establish proof-of-concept
If hypothesis is true, intervention require careful optimization of therapeutic interventions
pending conf: 0.60
Expected outcome: require careful optimization of therapeutic interventions
Falsified by: Intervention fails to require careful optimization of therapeutic interventions
If hypothesis is true, intervention be therapeutically exploited in neurodegenerative diseases where mitochondrial dysfunction is a central pathological feature
pending conf: 0.60
Expected outcome: be therapeutically exploited in neurodegenerative diseases where mitochondrial dysfunction is a central pathological feature
Falsified by: Intervention fails to be therapeutically exploited in neurodegenerative diseases where mitochondrial dysfunction is a central pathological feature
If hypothesis is true, intervention amplify the natural mitochondrial donation capacity represents a novel therapeutic strategy that leverages the brain's endogenous repair mechanisms
pending conf: 0.60
Expected outcome: amplify the natural mitochondrial donation capacity represents a novel therapeutic strategy that leverages the brain's endogenous repair mechanisms
Falsified by: Intervention fails to amplify the natural mitochondrial donation capacity represents a novel therapeutic strategy that leverages the brain's endogenous repair mechanisms

Knowledge Subgraph (31 edges)

activates (1)

Connexin-43astrocyte-to-neuron mitochondrial transfer

causal extracted (1)

sess_SDA-2026-04-01-gap-20260401231108processed

causes (9)

BNIP3/NIX inhibitionoxidative stressexcessive connexin-43 expressioncellular toxicityexcessive connexin-43 expressioncalcium homeostasis disruptionmitochondrial motility enhancementoxidative stressConnexin-43 deficiencyneuronal survival
▸ Show 4 more

enhances (1)

BNIP3/NIX inhibitionmitochondrial transfer efficiency

facilitates (2)

tunneling nanotubesmitochondrial transfertunneling nanotubesintercellular organelle transfer

modulates (3)

BNIP3/NIX inhibitionmitochondrial transfer efficiencyconnexin-43astrocyte-to-neuron mitochondrial transferConnexin-43tunneling nanotube formation

prevents (1)

Miro1 degradationdamaged mitochondrial spread

protective against (3)

astrocytesneuronal survivalmitochondrial transferneuronal bioenergeticsBNIP3/NIX inhibitionhealthy mitochondria preservation

regulates (5)

Miro1intercellular mitochondrial transferBNIP3/NIXmitochondrial turnoverF-actintunneling nanotube formationconnexin-43gap junction communicationBNIP3/NIXmitophagy

risk factor for (4)

Miro1 dysfunctionParkinson's diseaseinsufficient mitophagyneurodegenerationgap junction coupling excessseizuresgap junction coupling excesscardiac arrhythmias

therapeutic target for (1)

astrocytesbioenergetically compromised neurons

Mechanism Pathway for GJA1

Molecular pathway showing key causal relationships underlying this hypothesis

graph TD
    connexin_43["connexin-43"] -->|regulates| gap_junction_communicatio["gap junction communication"]
    tunneling_nanotubes["tunneling nanotubes"] -->|facilitates| intercellular_organelle_t["intercellular organelle transfer"]
    Miro1["Miro1"] -->|regulates| intercellular_mitochondri["intercellular mitochondrial transfer"]
    Miro1_dysfunction["Miro1 dysfunction"] -->|risk factor for| Parkinson_s_disease["Parkinson's disease"]
    Miro1_degradation["Miro1 degradation"] -->|prevents| damaged_mitochondrial_spr["damaged mitochondrial spread"]
    BNIP3_NIX["BNIP3/NIX"] -->|regulates| mitochondrial_turnover["mitochondrial turnover"]
    BNIP3_NIX_inhibition["BNIP3/NIX inhibition"] -->|modulates| mitochondrial_transfer_ef["mitochondrial transfer efficiency"]
    BNIP3_NIX_inhibition_1["BNIP3/NIX inhibition"] -->|causes| oxidative_stress["oxidative stress"]
    tunneling_nanotubes_2["tunneling nanotubes"] -->|facilitates| mitochondrial_transfer["mitochondrial transfer"]
    F_actin["F-actin"] -->|regulates| tunneling_nanotube_format["tunneling nanotube formation"]
    connexin_43_3["connexin-43"] -->|modulates| astrocyte_to_neuron_mitoc["astrocyte-to-neuron mitochondrial transfer"]
    excessive_connexin_43_exp["excessive connexin-43 expression"] -->|causes| cellular_toxicity["cellular toxicity"]
    style connexin_43 fill:#4fc3f7,stroke:#333,color:#000
    style gap_junction_communicatio fill:#4fc3f7,stroke:#333,color:#000
    style tunneling_nanotubes fill:#4fc3f7,stroke:#333,color:#000
    style intercellular_organelle_t fill:#4fc3f7,stroke:#333,color:#000
    style Miro1 fill:#4fc3f7,stroke:#333,color:#000
    style intercellular_mitochondri fill:#4fc3f7,stroke:#333,color:#000
    style Miro1_dysfunction fill:#4fc3f7,stroke:#333,color:#000
    style Parkinson_s_disease fill:#ef5350,stroke:#333,color:#000
    style Miro1_degradation fill:#4fc3f7,stroke:#333,color:#000
    style damaged_mitochondrial_spr fill:#4fc3f7,stroke:#333,color:#000
    style BNIP3_NIX fill:#4fc3f7,stroke:#333,color:#000
    style mitochondrial_turnover fill:#4fc3f7,stroke:#333,color:#000
    style BNIP3_NIX_inhibition fill:#4fc3f7,stroke:#333,color:#000
    style mitochondrial_transfer_ef fill:#4fc3f7,stroke:#333,color:#000
    style BNIP3_NIX_inhibition_1 fill:#4fc3f7,stroke:#333,color:#000
    style oxidative_stress fill:#4fc3f7,stroke:#333,color:#000
    style tunneling_nanotubes_2 fill:#4fc3f7,stroke:#333,color:#000
    style mitochondrial_transfer fill:#4fc3f7,stroke:#333,color:#000
    style F_actin fill:#4fc3f7,stroke:#333,color:#000
    style tunneling_nanotube_format fill:#4fc3f7,stroke:#333,color:#000
    style connexin_43_3 fill:#4fc3f7,stroke:#333,color:#000
    style astrocyte_to_neuron_mitoc fill:#4fc3f7,stroke:#333,color:#000
    style excessive_connexin_43_exp fill:#4fc3f7,stroke:#333,color:#000
    style cellular_toxicity fill:#4fc3f7,stroke:#333,color:#000

3D Protein Structure

🧬 GJA1 — PDB 7F94 Click to expand 3D viewer

Experimental structure from RCSB PDB | Powered by Mol* | Rotate: click+drag | Zoom: scroll | Reset: right-click

Source Analysis

Mitochondrial transfer between neurons and glia

neurodegeneration | 2026-04-01 | completed

Community Feedback

0 0 upvotes · 0 downvotes
💬 0 comments ⚠ 0 flags ✏ 0 edit suggestions

No comments yet. Be the first to comment!

View all feedback (JSON)

Same Analysis (5)

Miro1-Mediated Mitochondrial Trafficking Enhancement Therapy
Score: 0.55 · RHOT1
PINK1/Parkin-Independent Mitophagy Bypass for Enhanced Donor Mitochond
Score: 0.53 · BNIP3/BNIP3L
Synthetic Biology Approach: Designer Mitochondrial Export Systems
Score: 0.51 · Synthetic fusion proteins
Microglia-Derived Extracellular Vesicle Engineering for Targeted Mitoc
Score: 0.48 · RAB27A/LAMP2B
Optogenetic Control of Mitochondrial Transfer Networks
Score: 0.48 · ChR2
→ View all analysis hypotheses
Public annotations (0)Annotate on Hypothes.is →
No public annotations yet.